From a prospective and multicentric French cohort, we proposed an external validation study for the expanded criteria donor (ECD), based on 4833 kidney recipients transplanted for the first time between 2000 and 2014. We estimated the subjectspecific effect from a multivariable Cox model. We confirmed a 1.75-fold (95% confidence interval [CI] 1.53-2.00, P < .0001) increase in graft failure risk if a given patient received an ECD graft compared to a graft from a donor with standard criteria (standard criteria donor [SCD] ). Complementarily, we estimated the population-average effect using propensity scores. We estimated a 1.34-fold (95% CI 1.09-1.64, P = .0049) increase in graft failure risk among ECD patients receiving an ECD graft compared to receiving a SCD graft. With a 10-year follow-up, it corresponded to a decrease of 8 months of the mean time to graft failure due to ECD transplantation (95% CI 2-14 months). The population-average relative risk due to ECD transplantation and the corresponding absolute effect seem finally not so high. Regarding the increase of quality of life in transplantation, our study constitutes an argument to extend the definition of marginality by considering more grafts at high risk and thereby enlarging the pool of kidney grafts.
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| INTRODUCTION
Kidney transplantation is recognized as the best treatment for endstage renal disease in terms of morbidity, mortality, and quality of life.
1 Its development and expansion are limited on one hand by donor organ shortfalls, resulting in the search for new donors, and on the other hand by optimizing the use of available grafts. Due to an aging population, waiting lists are increasing, further exacerbating the need to increase successful transplants by extending the pool of available kidneys. 2 One possibility is to consider marginal grafts for kidney transplantation as they may deliver sufficient "renal function" to improve patient well-being.
In 2002, the expanded criteria donor (ECD) was proposed in the United States. 3 The ECD is defined as a donor older than 60 years, or between 50 and 59 years of age with at least 2 other comorbidities:
serum creatinine higher than 1.5 mg/dL, a history of high blood pressure, or a cerebrovascular accident (CVA) as the cause of donor death.
The ECD classification was proposed to obtain a subject-specific relative risk of graft failure equal to 1.7 compared to the standard criteria donor (SCD). More precisely, such a subject-specific effect can be interpreted as follows: on average, the graft failure risk for a given patient is multiplied by 1.7 if she/he received an ECD graft instead of an SCD graft.
We recently confirmed this subject-specific effect in a metaanalysis 4 based on 5 studies, [5] [6] [7] [8] [9] where we also demonstrated the lack of external validation studies for these criteria. Indeed, no European study was selected in this meta-analysis. However, Aubert et al 10 recently
confirmed these results in France. More recently, Ma et al 11 described that this effect seemed more important among younger recipients, whereas it could not be significantly shown for older recipients. In kidney transplantation, it is well known that ECD grafts are preferentially attributed to older recipients, resulting in a possible shift of the recipient age distributions between ECD and SCD recipients. A consequence may be the difficulty of interpreting the ECD transplantation effect among young recipients. Nevertheless, no report in the literature has examined this positivity assumption that requires that one can observe both ECD and SCD recipients at every combination of the values of the observed confounders.
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From a French prospective and observational cohort of kidney recipients, we proposed an external validation study of the subjectspecific effect of ECD transplantation. Beyond this scope, thanks to the recent developments in propensity score-based analyses and more generally in causal inference, the main objective of our study was to propose an alternative and complementary estimation by providing the absolute effect of ECD transplant organs on graft failure risk. More precisely, we compared for the first time the observed graft survival in ECD recipients and the expected graft survival if all ECD recipients had received SCD grafts. To ensure the robustness of this propensity score-based analysis, we paid special attention to the respect of the assumptions necessary to achieve causality. effect on the treated (ATT) effect, [20] [21] [22] that is, the patient-graft survival of ECD recipients in a counterfactual world in which these recipients would have instead received SCD graft. Logistic regression was used to compute propensity scores. Positivity assumption was graphically evaluated ( Figure S1 ). Standardized differences on the pseudo-population were all lower than 10%, illustrating that the propensity score-based analysis allows straightening up of the initial covariates' imbalance between ECD and SCD recipients. Adjusted survival curves were estimated by using the weighted Kaplan-Meier estimator. 23, 24 The corresponding restricted mean survival times were also estimated.
| MATERIALS AND METHODS

| Study population
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Concerning the subject-specific estimation, a pool of variables initially selected on univariable survival analysis (P < .20), as presented in Table S1 , was reduced to a lower number by a descending selection procedure (P < .05) in a multivariable Cox model. Then, to appraise the efficient confounding variables, each significant remaining variable was removed if it did not affect the estimation of the hazard ratio associated with ECD transplantation of more than 10%.
Concerning the population-average estimation, we first selected variables associated only with graft failure in univariable survival analysis (P < .20). Second, this pool of selected variables was included in a multivariable logistic regression and, then, reduced to a lower number by a descending selection procedure (P < .05), allowing the efficient confounding variables to be retained and the imprecision in the estimation to be limited. 26 The final retained variables were used to estimate the propensity score used to define ATT weights. Log-linearity assumption was graphically verified. Log-minus-log survival curves allowed graphical assessment of the proportional hazards assumption.
In addition, we studied the time from the transplantation to the death-censored graft failure and the time from the transplantation to the patient death with graft function (returns in dialysis were right censored). Note that we only reported relative risks by using a cause-specific approach to deal with competing events, that is, death with functioning graft and return in dialysis. Indeed, one can expect an important competition in the ECD population because of the age of recipients. We did not report the absolute effects, which would have been based on the cumulative incidence functions, for instance by using the Aalen-Johansen estimator. 27 However, to our knowledge, no one has developed this estimator in an inverse probability of treatment weighting framework.
In addition, we investigated the level of marginality within the ECD recipient cohort. We therefore performed a subgroup analysis by comparing the risk between recipients of ECD grafts from donors older than 75 years versus recipients of ECD graft from younger donors.
All analyses were performed using R software version 3.0.2.
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The IPW-based analyses were performed using the 0.4 version of the IPWsurvival package (www.labcom-risca.com).
| RESULTS
| Description of kidney transplant recipients at baseline
Among the 4833 studied patients, 2105 (44%) received an ECD graft and 2728 (56%) received an SCD graft. We observed a larger proportion of patients receiving an ECD graft compared to the 15% of ECD transplantation in the initial work of Port et al, 3 confirming that marginal grafts are increasingly used. We observed 25% of patients with a donor age between 50 and 59 years, 35% of patients had a donor older than 60 years, while 5% of patients had received a graft from a donor older than 75 years. The maximum donor age was 89 years. Moreover, 14% of donors presented a serum creatinine higher than 1.5 mg/dL and 31% of donors had history of high blood pressure. Fifty-seven percent of donors died of CVA, 28% died of trauma (including 12% of public road accident), 12% died from anoxia, and 3% died from others causes (intoxication, meningitides, tumor, and so on). Demographic characteristics of recipients are summarized in Table 1 . When comparing ECD and SCD recipients, significant differences were expected, notably concerning recipient age, since grafts were matched on age where possible. As also illustrated in Figure S2 , ECD kidneys are preferentially proposed for older recipients with a mean recipient age estimated at 61 years for ECD and 45 years for SCD (P < .0001). As might be expected, ECD recipients presented significantly more comorbidity histories than SCD recipients: notably concerning diabetes (20% for ECD vs 10% for SCD, P < .0001), dyslipidemia (37% for ECD vs 24% for SCD, P < .0001), and cardiovascular diseases (38% for ECD vs 26% for SCD, P < .0001).
| Description of follow-up
A total of 792 patients returned to dialysis and 488 patients died with a functioning graft. The causes of the recipient death were not col- (95% CI 56%-60%), respectively. Patient-graft survival curves for ECD and SCD kidney recipients are presented in Figure S3 . 
| Subject-specific effect on patient and graft survival
| Population-average effect on patient and graft survival
The recipient age was the only significant variable retained in the final logistic regression used to estimate the propensity score. This variable also appeared significantly associated with the patient-graft survival (Table S1 ). Table 3 presents the distribution of the characteristics of the pseudo-population obtained by propensity score weighting. In this pseudo-population, where the characteristics at baseline between ECD and SCD were balanced and comparable with the observed characteristics of the ECD recipients (fifth column of Table 1 ), we estimated a population-average relative risk of graft failure between the ECD and SCD groups at 1.34 (95% CI 1.09-1.64, P = .0049). In other words, we estimated a 1.34-fold decrease in risk of graft failure between patients who had received an ECD and the same patients if they had instead received an SCD graft. The corresponding patient-graft adjusted survival curves are presented in Figure 1 . The ECD curve represents the estimated patient-graft survival probability for ECD recipients of an ECD kidney while the SCD curve represents the estimated patient-graft survival probability for ECD patients in the hypothetical situation of receiving an SCD kidney. The survival rates at 3, 6, and 10 years posttransplantation were, respectively, 77%, 62%, and 40% for ECD recipients and 82%, 68%, and 53% for the comparable group of SCD recipients. Therefore, at 10 years posttransplantation, the absolute risk excess due to ECD transplantation was 13% (95% CI 2%-24%). This means that, if 100 patients followed-up to 10 years had received an SCD instead of an ECD graft, 13 graft failures would have been prevented. The corresponding number needed to treat was about 8 (95% CI 4-45), which means that we must transplant 8 patients with an SCD graft instead of an ECD graft to prevent one graft failure at 10 years posttransplantation. For a cohort with a 10-years follow-up, the mean time T A B L E 1 Description of recipient, donor, and transplantation characteristics for the sample of kidney transplanted patients (n = 4833) according the ECD/SCD transplantation 
| Cause-specific risk of graft failure and causespecific risk of death with functioning graft
As presented in Table S2 , we estimated a 1.84-fold increase in the population-average risk of death-censored graft failure between ECD and SCD recipients (95% CI 1.33-2.55). This population-average relative risk was 0.97 for the risk of death with graft function (95% CI 0.73-1.30).
| ECD grafts from donors older than 75 years versus ECD grafts from younger donors
We estimated a nonsignificant population-average relative risk of graft failure between patients with an ECD graft from donors older than 75 years versus recipients with an ECD graft from younger donors (hazard ratio [HR] 1.19, 95% CI 0.90-1.58). At 5 years posttransplantation, the graft survival was 46% (95% CI 28%-64%) in the recipients of older donors versus 60% (95% CI 45%-75%) in the recipients of younger donors. We therefore estimated an absolute risk increase due to donor age at 14% (95% CI-10%-38%). This nonsignificant difference was also observed for the risk of death with graft function (HR 0.98, 95% CI 0.64-1.51), and for the risk of death censored graft failure (HR 1.39, 95% CI 0.97-1.99). These estimates are also summarized in Table S2 .
| DISCUSSION
From the French multicentric DIVAT cohort, we confirmed that the subject-specific relative risk of graft failure between ECD and SCD is close to the one obtained in the initial study: HR 1.75 (95% CI 1.53- CI 0.73-1.30). Our propensity score-based approach presents a major interest, since it also provides confounder-adjusted absolute effects.
At 10 years after transplantation, the decrease in the mean time to graft failure due to ECD transplantation was estimated at 8 months (95% CI 2-14 months). We also described a difference of 13% in terms of patient and graft survival at 10 years after transplantation (95% CI 2%-24%), corresponding to a number needed to treat at 8 patients (95% CI 4-45).
The population-average effects of ECD transplantation may appear not so high in our population. 29 None of these scoring systems considers the interactions between donor and recipient characteristics. However,, the kidney graft marginalization should not be determined as an absolute criterion but should depend on the recipients' features.
In conclusion, even if our study confirmed the subject-specific relative risk related to ECD versus SCD, the population-average effects of ECD transplantation seemed not so important. Using a propensity score-based analysis, we proposed an alternative estimation of ECD transplantation at a population level, not better than the traditional multivariate modeling giving subject-specific estimation, but allowing a complementary interpretation. This study reinforces the idea of further increasing the pool of marginal kidneys. This perspective probably needs to integrate both the donor and recipient characteristics to better identify recipients who will benefit from being transplanting by such highly marginal grafts. 
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